🇺🇸 FDA
Patent

US 11702656

Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders

granted A61PA61P25/16A61P25/28

Quick answer

US patent 11702656 (Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders) held by The Regents of the University of California expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P25/16, A61P25/28